These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33433781)

  • 21. Therapeutic efficacy of olfactory stem cells in rotenone induced Parkinsonism in adult male albino rats.
    Abdel-Rahman M; Galhom RA; Nasr El-Din WA; Mohammed Ali MH; Abdel-Hamid AES
    Biomed Pharmacother; 2018 Jul; 103():1178-1186. PubMed ID: 29864896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.
    Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Domin H; Śmiałowska M; Głowacka U; Ossowska K
    Neuroscience; 2016 Feb; 314():22-34. PubMed ID: 26628402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation of neural stem cells co-transfected with Nurr1 and Brn4 for treatment of Parkinsonian rats.
    Tan X; Zhang L; Qin J; Tian M; Zhu H; Dong C; Zhao H; Jin G
    Int J Dev Neurosci; 2013 Feb; 31(1):82-7. PubMed ID: 23085081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Expression of Neuronal Dopaminergic Markers in a Parkinson's Disease Model in Rats Implanted with Enteric Stem Cells (ENSCs).
    Parra-Cid C; Orozco-Castillo E; García-López J; Contreras-Figueroa E; Ramos-Languren LE; Ibarra C; Carreón-Rodríguez A; Aschner M; Königsberg M; Santamaría A
    CNS Neurol Disord Drug Targets; 2020; 19(2):148-162. PubMed ID: 32303175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Puerarin promoted proliferation and differentiation of dopamine-producing cells in Parkinson's animal models.
    Shiying L; Xinhui Q; Guanghua J; Feng N; Feng L; Shumei C; Fan H
    Biomed Pharmacother; 2018 Oct; 106():1236-1242. PubMed ID: 30119192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.
    Wang F; Yasuhara T; Shingo T; Kameda M; Tajiri N; Yuan WJ; Kondo A; Kadota T; Baba T; Tayra JT; Kikuchi Y; Miyoshi Y; Date I
    BMC Neurosci; 2010 Apr; 11():52. PubMed ID: 20420688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of vagus nerve stimulation paradigms guide clinical development for Parkinson's disease.
    Farrand AQ; Verner RS; McGuire RM; Helke KL; Hinson VK; Boger HA
    Brain Stimul; 2020; 13(5):1323-1332. PubMed ID: 32629028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.
    Fu W; Zheng Z; Zhuang W; Chen D; Wang X; Sun X; Wang X
    Int J Neurosci; 2013 Dec; 123(12):883-91. PubMed ID: 23768098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic-primed fetal liver mesenchymal stromal-like cells can reverse parkinsonian symptoms in 6-hydroxydopamine-lesioned mice.
    Kumar A; Dudhal S; Sundari T A; Sunkara M; Usman H; Varshney A; Mukhopadhyay A
    Cytotherapy; 2016 Mar; 18(3):307-19. PubMed ID: 26857226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
    Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
    Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson's disease.
    Wang ZH; Ji Y; Shan W; Zeng B; Raksadawan N; Pastores GM; Wisniewski T; Kolodny EH
    Neuroscience; 2002; 113(3):629-40. PubMed ID: 12150782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult human olfactory epithelial-derived progenitors: a potential autologous source for cell-based treatment for Parkinson's disease.
    Wang M; Lu C; Roisen F
    Stem Cells Transl Med; 2012 Jun; 1(6):492-502. PubMed ID: 23197853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
    Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease.
    Azzouz M; Martin-Rendon E; Barber RD; Mitrophanous KA; Carter EE; Rohll JB; Kingsman SM; Kingsman AJ; Mazarakis ND
    J Neurosci; 2002 Dec; 22(23):10302-12. PubMed ID: 12451130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy.
    Bagheri-Mohammadi S; Alani B; Karimian M; Moradian-Tehrani R; Noureddini M
    Mol Biol Rep; 2019 Aug; 46(4):4293-4302. PubMed ID: 31123907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
    J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.
    Suzuki S; Kawamata J; Iwahara N; Matsumura A; Hisahara S; Matsushita T; Sasaki M; Honmou O; Shimohama S
    Neurosci Lett; 2015 Jan; 584():276-81. PubMed ID: 25449872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-β1 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson's disease models and patients.
    Zhuo Y; Li WS; Lu W; Li X; Ge LT; Huang Y; Gao QT; Deng YJ; Jiang XC; Lan ZW; Deng Q; Chen YH; Xiao Y; Lu S; Jiang F; Liu Z; Hu L; Liu Y; Ding Y; He ZW; Tan DA; Duan D; Lu M
    Mil Med Res; 2024 Jul; 11(1):48. PubMed ID: 39034405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.